Navigation Links
Hoag Breast Care Center Installs Xoft Electronic Brachytherapy System for IORT Program
Date:6/30/2010

novative treatment options available.  Reinforced by several recent studies demonstrating the clinical benefits of IORT, we strongly believe that the Xoft Electronic Brachytherapy System gives us the ability to provide positive clinical results in the safe and patient friendly environment patients have come to know from Hoag."  

Available for treatment of early stage breast cancer, endometrial cancer, and skin cancer, the Axxent eBx System is also FDA cleared for use in the treatment of surface cancers or conditions where radiation therapy is indicated, including IORT (intraoperative radiation therapy). As a platform technology, the Axxent System is designed to deliver non-radioactive therapy directly to cancer sites with minimal radiation exposure to surrounding healthy tissue. Utilizing a proprietary miniaturized X-ray source and robotic controller, treatment can be performed in minimally shielded therapeutic settings allowing the radiation oncologist and other medical personnel to be present during treatment delivery and minimizing patient anxiety.

"We are proud to work with Dr Silverstein and the team at Hoag Breast Care Center to offer this breakthrough treatment for breast cancer that delivers definitive therapy in a matter of minutes rather than weeks or even days," said Michael Klein, Xoft CEO and president. "We are encouraged that the clinical value of isotope-free electronic treatment for IORT and accelerated brachytherapy applications continues to be reinforced by multiple study publications, including the recent TARGIT study. We strongly believe that utilization of Electronic Brachytherapy will continue to increase not only on their ability to improve patient care but also as a result of the convenient approach to treatment."  

About Hoag Cancer Center

Hoag Cance
'/>"/>

SOURCE Xoft
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014  Australian drug delivery ... that it has raised A$19.3 million via a placement ... Europe , the U.S., Asia ... million from a share purchase plan (SPP) to be ... will be made in two tranches. "This ...
(Date:7/11/2014)... , July 11, 2014  Veran Medical ... announced today the positive, cost-effective final results ... SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous biopsy ... percutaneous approach to biopsy when a traditional ... and physicians experience positive financial outcomes when ...
(Date:7/10/2014)... NEWS, Virginia , 11. Juli ... Hersteller von Kameras für die molekulare ... (MBI/BSGI), hat heute die CE-Zulassung für ... dem CE-Zeichen kann Dilon das Produkt ... Vertriebsbereich auf den Großteil der europäischen ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Veran Medical Publishes Lung Cancer Patient Management Study 2Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2
... , Part of International Internet Week ... The U.S. Food and Drug Administration today completed ... Week of Action (IIWA), intended to curb illegal actions ... During the effort, the FDA,s Office of Criminal Investigations ...
... , Primary Care Doctors, Endocrinologists Feel ... N.J., Nov. 19 Nearly one-third of doctors surveyed said ... sufficient reimbursement to provide comprehensive care to their patients with ... and primary care doctors published today in American Health ...
Cached Medicine Technology:UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 2Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 3Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 4Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 5
(Date:7/11/2014)... The report “Probiotics Market by ... Feed), Applications (Regular, Therapeutic, Preventive Health Care) & ... Forecasts to 2019 ” defines and segments the ... of the market value of probiotic products and ... restraining factors for the global market with an ...
(Date:7/11/2014)... Global enterprises today are shifting towards the changing trend ... services offer these global enterprises a strategic method to ... rising operational costs to companies. The aim to minimize ... global market driver for expanding the managed services market ... is estimated to grow from $142.75 billion in 2013 ...
(Date:7/11/2014)... Toledo, Ohio (PRWEB) July 11, 2014 ... (Morgenson 7/10/14) and FiercePharma (Weintraub 7/11/14), a significant number ... in blood sugar, abdominal issues and even death from ... exposed. , According to the Times report , ... events in 2013 reported by patients was almost 14% ...
(Date:7/11/2014)... its kind has found that organic foods and ... conventional counterparts, including more antioxidants and fewer, less ... an unprecedented 343 peer-reviewed publications comparing the nutritional ... foods, including fruits, vegetables, and grains. The study ... between organic and non-organic foods. , "Science ...
(Date:7/11/2014)... HealthDay Reporter THURSDAY, July 10, 2014 ... the worldwide scourge of dengue fever was somewhat successful in ... prevented dengue fever in 56 percent of the 10,000 kids ... more than 88 percent of them from severe disease. In ... sometimes death. "This vaccine has already proven to be ...
Breaking Medicine News(10 mins):Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:Acthar’s Deadly Adverse Events Revealed 2Health News:Acthar’s Deadly Adverse Events Revealed 3Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3
... 1 (HealthDay News) -- Increasing daily soluble fiber intake may ... other substances linked to a host of chronic diseases, according ... found just under the skin, visceral fat is located deep ... Researchers at Wake Forest Baptist Medical Center found the way ...
... believe medical practitioners can help reduce the number of ... effectively educating their patients about the importance of mammography ... the Journal of Cancer Education , Rosalie Young, ... and Jason Booza, Ph. D., assistant professor, all from ...
... Researchers from the University of Leeds will carry out a ... or treat the spread of bowel cancer to the liver. ... of pure Eicosapentaenoic Acid (EPA) - a naturally occurring omega-3 ... oil preparations in health stores and supermarkets nationwide. Gastroenterologist ...
... (MGH) researchers have discovered the first of an entirely ... with the development of blood vessels. In a report ... /Early Edition, the investigators describe how a compound derived ... novel mechanism, to interfere with blood vessel formation in ...
... The Obama administration turned a bright spotlight on prescription ... Drug Control Policy released a national action plan and ... cover article in the July edition of the ... focus that spotlight on themselves both as major sources ...
... Bill Keevil, Head of the Microbiology Group and ... University of Southampton, has presented research into the ... on antibiotic-resistant organisms at the World Health Organization,s ... (ICPIC). ,New Insights into the Antimicrobial Mechanisms ...
Cached Medicine News:Health News:Soluble Fiber Appears Key to Trimming 'Bad Fat' 2Health News:Health providers should emphasize breast cancer screening, Wayne State University research finds 2Health News:Leeds researchers test benefit of fish oil in bowel cancer spread 2Health News:Mass. General team identifies new class of antiangiogenesis drugs 2Health News:Research examines dentists' role in painkiller abuse 2Health News:Research examines dentists' role in painkiller abuse 3Health News:Copper reduces infection risk by more than 40 percent 2
...
... accommodate a variety of applications across a ... DestinyPlus is suitable for any laboratory demanding ... a mixed-mode throughput exceeding 95 PT/aPTT/Fibrinogen per ... full range of chromogenics, the AMAX DestinyPlus ...
Non-invasive and continuous tcpCO2 and tcpO2 patient monitoring....
Two separate sensors provide continuous measurement of tcpO2/tcpCO2 and SpO2....
Medicine Products: